genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
GeoVax
GEN Edge
GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge
StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
News
CalciMedica – Auxora™ (formerly CM4620-IE)
Infectious Diseases
GeoVax Extends NIAID Collaboration to Ebola, Marburg Vaccines
Bioprocessing
GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66 Cells
Drug Discovery
GeoVax Labs Receives $0.8M Funding Boost from NIAID to Progress HIV Vaccine
Bioprocessing
GeoVax Receives Latest Tranche of $19.6M NIAID Funding for HIV Vaccine
Drug Discovery
Formatech to Donate Services to Formulate and Fill a GeoVax HIV Vaccine
Scroll Up
Scroll Up
